Status | Study |
Recruiting |
Study Name: Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy Condition: Leber Hereditary Optic Neuropathy Date: 2017-05-10 Interventions: Drug: rAAV2-ND4 a Single IVT I |
Recruiting |
Study Name: Biomechanics of Optic Neuropathy Condition: Optic Neuropathy Date: 2016-08-28 Interventions: Device: magnetic resonance image (MRI) |
Recruiting |
Study Name: Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON) Condition: Leber's Hereditary Optic Neuropathy (LHON) Date: 2016-06-07 |
Recruiting |
Study Name: Surgery for Traumatic Optic Neuropathy Condition: Traumatic Optic Neuropathy Date: 2016-03-06 Interventions: Procedure: Optic canal and optic nerve sheath decompression |
Active, not recruiting |
Study Name: A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic Neuropathy Condition: Leber's Hereditary Optic Neuropathy Date: 2016-02-15 Interventions: Drug: elamipretide (MTP-131) 1% topical ophthalmic solution |
Active, not recruiting |
Study Name: Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells Condition: Optic Neuropathy Date: 2015-12-07 Interventions: Biological: Stem Cells Intervention: Transplantation of autologous purified stem cells |
Recruiting |
Study Name: Choroidal Thickness in Optic Neuropathy Condition: Optic Nerve Disorders Date: 2015-03-02 |
Recruiting |
Study Name: Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study) Condition: Optic Nerve Diseases Date: 2015-02-17 Interventions: Drug: Erythropoietin 20,000 IU |
Completed |
Study Name: CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS Condition: Chronic Optic Neuropathy in Multiple Sclerosis Date: 2014-06-25 Interventions: Procedure: • Neuro-Ophthalmological examination, Visual Acuity, Fundus, Visual Field, Color Vision, OCT, EDSS • NEI-VFQ 25 and the 10-item |
Recruiting |
Study Name: Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy Condition: Leber's Hereditary Optic Neuropathy Date: 2014-06-06 Interventions: Drug: injection of scAAV2-P1ND4v2 5.00x10e9 vg (Low), |